Aurobindo Pharma Unit Gets USFDA Observations
By Rediff Money Desk, NEWDELHI Apr 05, 2024 18:26
Aurobindo Pharma's subsidiary, Eugia Steriles, received three observations from the USFDA after an inspection of their new injectable facility in Andhra Pradesh.
New Delhi, Apr 5 (PTI) Aurobindo Pharma on Friday said the US health regulator has issued three observations after inspecting the Andhra Pradesh-based manufacturing unit of its subsidiary.
The US Food and Drug Administration (USFDA) inspected the new injectable facility of Eugia Steriles, a step-down subsidiary of the company, situated in Anakapalli district of Andhra Pradesh, from March 28 to April 5, 2024, the drug firm said in a regulatory filing.
The inspection closed with three observations, it added.
The observations are procedural in nature and will be responded to within the stipulated time, Aurobindo Pharma said.
Shares of the company on Friday ended 0.02 per cent lower at Rs 1,123.75 apiece on the BSE.
The US Food and Drug Administration (USFDA) inspected the new injectable facility of Eugia Steriles, a step-down subsidiary of the company, situated in Anakapalli district of Andhra Pradesh, from March 28 to April 5, 2024, the drug firm said in a regulatory filing.
The inspection closed with three observations, it added.
The observations are procedural in nature and will be responded to within the stipulated time, Aurobindo Pharma said.
Shares of the company on Friday ended 0.02 per cent lower at Rs 1,123.75 apiece on the BSE.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 8.21 ( -5.09)
- 50736618
- AvanceTechnologies
- 0.64 ( -5.88)
- 23261214
- Srestha Finvest
- 0.63 ( -3.08)
- 17968849
- Vakrangee
- 16.71 (+ 4.96)
- 14316214
- G G Engineering
- 1.11 ( -4.31)
- 13184477
MORE NEWS

Sensex, Nifty Slide 8th Day: FPI Outflows, Weak...
Sensex and Nifty extended their losing streak for the eighth day due to foreign fund...
EaseMyTrip Q3 Profit Down to Rs 34 Cr
EaseMyTrip's net profit fell to Rs 34 crore in Q3 FY23, down from Rs 45.68 crore in the...

Cordelia Cruises IPO: Rs 800 Cr to Fund Growth...
Cordelia Cruises plans to raise Rs 800 crore through an IPO to fund its growth plans,...